There is just no way they can honestly plan to fund Elto w dilution they have to know after speaking about revenue changing math and shareholder value that it would really hurt the CEOs credibility and hurt the stock immediately and moving forward
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links